270 related articles for article (PubMed ID: 21710324)
1. Impact of pegylated interferon therapy on outcomes of patients with hepatitis C virus-related hepatocellular carcinoma after curative hepatic resection.
Tanimoto Y; Tashiro H; Aikata H; Amano H; Oshita A; Kobayashi T; Kuroda S; Tazawa H; Takahashi S; Itamoto T; Chayama K; Ohdan H
Ann Surg Oncol; 2012 Feb; 19(2):418-25. PubMed ID: 21710324
[TBL] [Abstract][Full Text] [Related]
2. Combination PEG-IFN a-2b/ribavirin therapy following treatment of hepatitis C virus-associated hepatocellular carcinoma is capable of improving hepatic functional reserve and survival.
Ishikawa T; Higuchi K; Kubota T; Seki K; Honma T; Yoshida T; Kamimura T
Hepatogastroenterology; 2012; 59(114):529-32. PubMed ID: 22024226
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of adjuvant pegylated interferon therapy for metastatic tumor antigen 1-positive hepatocellular carcinoma.
Lee D; Chung YH; Kim JA; Park WH; Jin YJ; Shim JH; Ryu SH; Jang MK; Yu E; Lee YJ
Cancer; 2013 Jun; 119(12):2239-46. PubMed ID: 23564564
[TBL] [Abstract][Full Text] [Related]
4. Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.
Hagihara H; Nouso K; Kobayashi Y; Iwasaki Y; Nakamura S; Kuwaki K; Toshimori J; Miyatake H; Ohnishi H; Shiraha H; Yamamoto K
Int J Clin Oncol; 2011 Jun; 16(3):210-20. PubMed ID: 21152943
[TBL] [Abstract][Full Text] [Related]
5. Effect of sustained virological response to interferon therapy for hepatitis C to the hepatectomy for primary hepatocellular carcinoma.
Tsujita E; Maeda T; Kayashima H; Harada N; Tsutsui S; Matsuda H; Kinjo N; Ikeda Y; Morita M; Ishida T
Hepatogastroenterology; 2015; 62(137):157-63. PubMed ID: 25911888
[TBL] [Abstract][Full Text] [Related]
6. The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment.
Kuo YH; Wang JH; Chang KC; Hung CH; Lu SN; Hu TH; Yen YH; Kee KM; Chen CH
Invest New Drugs; 2020 Feb; 38(1):202-210. PubMed ID: 31701431
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma--A retrospective multicenter study.
Harada N; Hiramatsu N; Oze T; Tatsumi T; Hayashi N; Takehara T
J Med Virol; 2015 Jul; 87(7):1199-206. PubMed ID: 25772024
[TBL] [Abstract][Full Text] [Related]
8. Impact of Sustained Virological Response to Interferon Therapy on Recurrence of Hepatitis C Virus-Related Hepatocellular Carcinoma.
Shinkawa H; Hasegawa K; Arita J; Akamatsu N; Kaneko J; Sakamoto Y; Kokudo N
Ann Surg Oncol; 2017 Oct; 24(11):3196-3202. PubMed ID: 28707053
[TBL] [Abstract][Full Text] [Related]
9. Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy.
Nishibatake Kinoshita M; Minami T; Tateishi R; Wake T; Nakagomi R; Fujiwara N; Sato M; Uchino K; Enooku K; Nakagawa H; Asaoka Y; Shiina S; Koike K
J Hepatol; 2019 Jan; 70(1):78-86. PubMed ID: 30336183
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection.
Chen LT; Chen MF; Li LA; Lee PH; Jeng LB; Lin DY; Wu CC; Mok KT; Chen CL; Lee WC; Chau GY; Chen YS; Lui WY; Hsiao CF; Whang-Peng J; Chen PJ;
Ann Surg; 2012 Jan; 255(1):8-17. PubMed ID: 22104564
[TBL] [Abstract][Full Text] [Related]
11. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
Xu J; Li J; Chen J; Liu ZJ
Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
[TBL] [Abstract][Full Text] [Related]
12. Serum antibody titers against hepatitis C virus and postoperative intrahepatic recurrence of hepatocellular carcinoma.
Uemura M; Sasaki Y; Yamada T; Gotoh K; Eguchi H; Yano M; Ohigashi H; Ishikawa O; Imaoka S
Ann Surg Oncol; 2014 May; 21(5):1719-25. PubMed ID: 24464342
[TBL] [Abstract][Full Text] [Related]
13. Interferon-α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus-related hepatocellular carcinoma.
Qu LS; Jin F; Huang XW; Shen XZ
J Surg Oncol; 2010 Dec; 102(7):796-801. PubMed ID: 20886584
[TBL] [Abstract][Full Text] [Related]
14. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
[TBL] [Abstract][Full Text] [Related]
15. Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.
Cardoso AC; Moucari R; Figueiredo-Mendes C; Ripault MP; Giuily N; Castelnau C; Boyer N; Asselah T; Martinot-Peignoux M; Maylin S; Carvalho-Filho RJ; Valla D; Bedossa P; Marcellin P
J Hepatol; 2010 May; 52(5):652-7. PubMed ID: 20346533
[TBL] [Abstract][Full Text] [Related]
16. Second hepatectomy for recurrent hepatocellular carcinoma achieved sustained virological response to interferon therapy for hepatitis C.
Tsujita E; Yamashita Y; Takeishi K; Maeda T; Takaki S; Mori N; Aisaka Y; Furukawa Y; Shirabe K; Ishida T; Maehara Y
Hepatogastroenterology; 2013; 60(128):2048-54. PubMed ID: 24088310
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy after curative treatment for hepatocellular carcinoma.
Kudo M
Oncology; 2011; 81 Suppl 1():50-5. PubMed ID: 22212936
[TBL] [Abstract][Full Text] [Related]
18. Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma.
Hsu YC; Ho HJ; Wu MS; Lin JT; Wu CY
Hepatology; 2013 Jul; 58(1):150-7. PubMed ID: 23389758
[TBL] [Abstract][Full Text] [Related]
19. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.
Uenishi T; Nishiguchi S; Tanaka S; Yamamoto T; Takemura S; Kubo S
J Surg Oncol; 2008 Oct; 98(5):358-62. PubMed ID: 18646001
[TBL] [Abstract][Full Text] [Related]
20. Antiviral therapy after non-surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus.
Hung CH; Lee CM; Wang JH; Tung HD; Chen CH; Lu SN
J Gastroenterol Hepatol; 2005 Oct; 20(10):1553-9. PubMed ID: 16174073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]